Cargando…
Both radiographical and pathological lymph node statuses are independent predictors for survival following neoadjuvant chemotherapy and radical cystectomy for cT3/4 or cN+ bladder cancer
INTRODUCTION: Urothelial bladder cancer (UBC) with clinical suspicion of locally advanced growth or pelvic lymphogenic spread has a high risk of progression and death. PATIENTS AND METHODS: Bladder cancer patients with locally advanced (cT3/4) tumor growth or suspected pelvic lymphogenic spread (cN+...
Autores principales: | Wagner, Julia, Simon, Ricarda, Büchler, Jakob Wolf, Kirchhoff, Florian, Kehl, Viktoria, Retz, Margitta, Gschwend, Juergen Erich, Sauter, Andreas, Horn, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849310/ https://www.ncbi.nlm.nih.gov/pubmed/36269368 http://dx.doi.org/10.1007/s00345-022-04187-w |
Ejemplares similares
-
Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer – study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)
por: Schmid, Sebastian C., et al.
Publicado: (2020) -
[(11)C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy
por: Schwarzenböck, Sarah M., et al.
Publicado: (2016) -
The timing of radical cystectomy following neoadjuvant chemotherapy
por: Ramakrishnan, Venkat M., et al.
Publicado: (2018) -
Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients
por: Heck, Matthias M., et al.
Publicado: (2013) -
Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
por: Babst, Christa, et al.
Publicado: (2022)